For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Scientific Program

FP102

4295N

Dr.Chandra lakshmi C
Membership No Author Name Email Mobile
4295N Dr.Chandra lakshmi C chandumay1@yahoo.com 9871554298
Medical Retina

FOUR-WEEK RENAL SAFETY PROFILE OF INTRAVITREAL RAZUMAB IN MACULAR EDEMA: A PROSPECTIVE PILOT STUDY 

PURPOSE:To evaluate the effect of the intravitreal Anti-VEGF(RAZUMAB)on renal parameters of treatment-naïve eyes for macular edema.METHODS:A cross-sectional prospective study of n= 15 eyes receiving intravitreal injection for the treatment of macular edema was evaluated.The demographics,renal parameters such as S.urea,S.creatinine,Urine PCR(protein creatine ratio)were assessed at baseline and 4weeks post injection.Visual acuity(BCVA),Central macular thickness(CMT)and BP values(pre- and post-injections) were recorded.BCVA,change in CMT and renal parameters pre and post injections were analyzed.RESULTS:Mean Age was 56years.DME(Diabetic macular edema)in 60%and Retinal vein related macular edema in 40%.The CMT pre and post injections were 411 and 326 μm respectively.CMT was statistically significant with p=0.0001.The change in e-GFR was not statistically significant with p=0.58(p >0.05).CONCLUSIONS:Intravitreal Razumab did not significantly cause any change in renal parameters in our study

Membership No Author Name Email Mobile
1385 Dr.Prathibha S prathibhas@rediffmail.com 9986485551
2860 Dr.REETHA B T reethab11@gmail.com 9900958888
2231 Dr.Shilpa S Reddy drshilpa68@gmail.com 9538712766